AC Immune Showcasing Its Novel Morphomer Antibody Drug Conjugate Moradc Platform For The Treatment of Neurodegenerative Diseases at Aaic 2024

Tuesday, July 16, 2024 1 min read

Key Takeaway: AC Immune Showcasing Its Novel Morphomer Antibody Drug Conjugate Moradc Platform For The Treatment of Neurodegenerative Diseases at Aaic 2024

Full Press Release Details

AC Immune Showcasing Its Novel Morphomer Antibody Drug Conjugate Moradc Platform For The Treatment of Neurodegenerative Diseases at Aaic 2024.

FDA Calendar

BPW Portfolio

Historical FDA Calendar

Market Movers

Biotech Earning Calendar

Historical PDUFA Dates

PDUFA Calendar

Conference Calendar

IPO

Catalyst Sync™

Hedge Fund Screener

Company Screener

All Stocks Holdings

Heat-Map

Inside Trades

Biotech Analyst Ratings

M&A Tracker

News

Blogs

Modality Leaderboard

Discord

User Guide

Biotech Investing 101

Recent Updates

Recently added Catalysts

Full Press Release Details